Exyte, the German construction and engineering company, has released its financial report for the first three months of 2019. The latest financial report shows €852 million in sales, a 13% growth year-on-year.
The Advanced Technology Facilities (ATF), which serves Exyte’s customers in the semiconductor industry, remains the company’s strongest business segment with sales of €722m, up 26% on Q1 2018.
Exyte said the business continues to capitalise on the global megatrends in the Life Sciences & Chemicals (LSC) and Data Center (DTC) segments of digitalisation, Industry 4.0, and the ever-expanding global population. The company believes these trends will accelerate demand.
Exyte CEO, Dr Wolfgang Büchele, commented: “We are very satisfied with business performance over the first three months of the current financial year. This growth path underlines once again the huge potential of our company and confirms that our strategic business segment realignment to focus on advanced technology facilities, life sciences and chemicals and the data centre sectors, as well as the various strategic initiatives we have kicked off, are yielding the desired results.”
Multimillion-euro order book
Exyte's financial report acknowledged a decline in the order intake in the Q1 2019 compared with the previous year as the order book for this period shows €1.2 billion. The company said the drop was expected following a 24% average increase per annum in the order intake since 2015 as major projects were booked in Q1/2018. "Exyte’s order books remain well-filled, however, with an order backlog of € 3.3 billion,' reads the statement.
The Asia-Pacific (APAC) and Europe (EMEA) regions, in particular, performed well in the first three months of the current financial year.
In the APAC region, where Exyte focuses on the semiconductor market, sales increased by just under 10% (Q1/2019: € 499 million). Exceptional growth in EMEA, meanwhile, saw €262 million in sales, up 77% compared with the same period a year ago.
“Our impressive growth in both Asia-Pacific and Europe demonstrates yet again the strong global reach of our company,” said Exyte CFO Wolfgang Homey. “We will continue to drive our ambitious growth plans across our strategic core markets and strengthen our market positions further," he added.
Exyte has confirmed its forecast for 2019 and expects to generate more sales than the previous year when the company achieved € 3.5 billion,
Order intake is believed to be slightly below the record level of 2018 of €4.4 billion.
